The other 115 patients were with 1) other causative PD mutations or 2) risk variants (including two patients with both Parkin single heterozygous mutation and other PD‐related risk variants, six patients with single heterozygous mutation) or 3) variants ranked as likely pathogenic or VUS or 4) homozygous Parkin mutations plus one other PD‐related risk variant (one patient). The gene discussed is PRKN; the disease is Parkinson disease.